Ion Beam Applications SA (EBR: IBAB)

Market Cap	384.61M
Revenue (ttm)	465.75M
Net Income (ttm)	7.85M
Shares Out	29.18M
EPS (ttm)	0.27
PE Ratio	48.95
Forward PE	20.76
Dividend	0.17 (1.34%)
Ex-Dividend Date	Jun 19, 2024

Volume	5,069
Average Volume	14,004
Open	12.72
Previous Close	12.68
Day's Range	12.72 - 13.20
52-Week Range	9.31 - 15.14
Beta	1.01
RSI	47.95
Earnings Date	Mar 20, 2025

About Ion Beam Applications

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclot...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 2,145
• Stock Exchange: Euronext Brussels
• Ticker Symbol: IBAB